ORPHENADRINE CITRATE (ORPHENADRINE CITRATE) — FDA Approval ANDA085046 (SANDOZ)
ORPHENADRINE CITRATE (ORPHENADRINE CITRATE) — FDA Approval ANDA085046 (SANDOZ) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: ORPHENADRINE CITRATE; Active ingredients: ORPHENADRINE CITRATE; Application number: ANDA085046.
| Brand name | ORPHENADRINE CITRATE |
|---|---|
| Active ingredients | ORPHENADRINE CITRATE |
| Application number | ANDA085046 |
| Sponsor | SANDOZ |
| Dosage form | TABLET, EXTENDED RELEASE |
| Route | ORAL |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 19820629 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →